top of page

Market Access - Brazil

HTAnalyze supports organizations in critical market access, pricing, and value demonstration projects by integrating clinical evidence, HEOR (Health Economics and Outcomes Research), budget impact analysis, and RWE (Real-World Evidence) into robust, transparent, and traceable deliverables.

 

We operate extensively across key healthcare decision-making pathways in Brazil, including Conitec, ANS, and CMED, and have the technical capacity to support international market access and reimbursement strategies.

HtAnalyze.11.png

Market Access – Brazil

Conitec (SUS) Submissions

We develop submissions to Conitec with methodological rigor and complete deliverables, integrating clinical evidence, economic evaluation, and budgetary impact for decisions within the SUS (Brazilian Public Health System).

HTANALYZE.png

Public consultations: analysis and technical contributions

We support companies and institutions in building consistent contributions and responses, with a clear narrative, scientific backing, and strategic positioning.

HTANALYZE.2.png

Preliminary assessment of submission feasibility
 

We mapped the scenario and maturity of the dossier to guide the decision: submit, supplement evidence, or revise strategy.

 

HTANALYZE.4.png

ANS Submissions (List)

We structure dossiers and analyses for submissions to the ANS (Brazilian National Agency for Supplementary Health), with methodological rigor, clarity in the value proposition, and alignment with regulatory deadlines.

HT.png

CMED Price Dossier
 

We structure CMED price dossiers with technical and documentary consistency, integrating references, comparators, and justifications in accordance with regulations.

 

HTANALYZE.3.png

Support for submission and technical defense.

We offer comprehensive support for technical submission and defense, including technical forms such as FormRol, presentation preparation, strategic alignment, and support in conducting meetings with decision-making committees.

ChatGPT Image 29_07_2026, 17_32_57.png

© 2026 HTAnalyze Consultoria e Treinamento LTDA and HTAnalyze Global LLC

bottom of page